Cipla's Strategic Foray into Weight Management

NEW DELHI: In a bold move to diversify its portfolio, Cipla, a leading drug manufacturer, is set to enter the weight management segment in India. This strategic initiative was disclosed by Umang Vohra, the company's MD and global CEO, in the annual report for FY25.

Strengthening Presence in Therapeutic Areas

Alongside its venture into weight management, Cipla is also focusing on enhancing its footprint in the central nervous system therapeutic area, signaling a comprehensive approach to healthcare solutions.